✦ LIBER ✦

The economics of basiliximab (Simulect) in preventing acute rejection in renal transplantation

✍ Scribed by James B. Chilcott; Michael W. Holmes; Stephen Walters; Ronald L. Akehurst; Björn Nashan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The economics of basiliximab (Simulect)

✍ James B. Chilcott,Michael W. Holmes,Stephen Walters… 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 296 KB

Simulect (basiliximab) reduces acute cel

✍ L.L Mulloy; F Wright; M.L Hall; M Moore 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 414 KB

101Basiliximab (Simulect®) reduces the r

✍ NEUHAUS, P; NASHAN, B; CLAVIEN, P; KITTUR, D; SALIZZONI, M; RIMOLA, A; ABEYWICKR 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB

Antithymocyte globulin more effective th

✍ Poole, Raewyn 📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 151 KB

Tacrolimus-Basiliximab versus Cyclospori

✍ D.Martin Garcia; J.Martin Gago; A Mendiluce; R Gordillo; J Bustamente 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Basiliximab in the therapy of acute reje

✍ M.N Chariat; M Erren; M Chariat; M Deng; H.H Wolters; K.H Dietl 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 95 KB